Clinical-stage #genetherapy company using its proprietary, redosable gene delivery platform to develop innovative treatments for #rarediseases. http://bit.ly/KrystalCG
Location: United States, Pennsylvania, Erie
Employees: 51-200
Founded date: 2015
Founders name: Suma Krishnan
Investors 1
Date | Name | Website |
- | Frazier Li... | frazierls.... |
Persons 2
Date | First Name | Last Name | Title | Location | |||
- | Chris | Mason | Director, ... | linkedin.c... | - | - | - |
- | Suma | Krishnan | Founder &a... | linkedin.c... | - | - | - |
Mentions in press and media 23
Date | Title | Description | Source |
26.04.2024 | Krystal Biotech to Report First Quarter 2024 Financial Resul... | PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS),... | einpresswi... |
08.02.2024 | Krystal Biotech Announces Publication in the New England Jou... | • Initial clinical data suggest the potential of B-VEC to treat lesions in the eye of DEB patients a... | einpresswi... |
03.07.2023 | Krystal Biotech Announces First Patient Dosed in Phase 1 Cli... | /EIN News/ -- PITTSBURGH, July 03, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (N... | einpresswi... |
22.05.2023 | Krystal Biotech Announces $160 Million Private Placement Equ... | /EIN News/ -- PITTSBURGH, May 22, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASD... | einpresswi... |
22.05.2023 | Krystal Biotech Announces $160 Million Private Placement Equ... | - | globenewsw... |
03.02.2022 | Power Moves: Krystal Biotech’s CBO hire marks continuing gro... | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new... | technical.... |
19.01.2022 | Krystal Biotech : Appoints Jing Marantz, MD, PhD, MBA as Chi... | Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, M... | marketscre... |
01.12.2021 | Krystal Biotech Announces Pricing of $200 Million Public Off... | PITTSBURGH, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), ... | marketscre... |
30.11.2021 | Krystal Biotech Announces Proposed $200 Million Public Offer... | PITTSBURGH, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), ... | marketscre... |
30.11.2021 | Krystal Biotech Announces Pricing of $200 Million Public Off... | PITTSBURGH, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), ... | globenewsw... |
Show more